SCHEMBL27975255

SCHEMBL27975255

Nc1nc2nc[nH]c2c(=O)n1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PNP P00491 1/20 0.49
▸ DPP4 P27487 1/20 0.46
▸ PDPK1 O15530 1/20 0.44
▸ GDA Q9Y2T3 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.42
▸ CDK2 P24941 3/20 0.42
▸ MAP3K5 Q99683 1/20 0.39
▸ PI4KA P42356 2/20 0.38
▸ PI4K2B Q8TCG2 2/20 0.38
▸ PI4K2A Q9BTU6 2/20 0.38
▸ PI4KB Q9UBF8 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ XDH P47989 1/20 0.38
▸ LRRK2 Q5S007 1/20 0.38
▸ ATAD2 Q6PL18 1/20 0.38
▸ HRH4 Q9H3N8 1/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ PIK3CD O00329 1/20 0.37
▸ ALPL P05186 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL27779727 0.92 PNP (0.43) PNPDPP4PDPK1GDAALDH1A1
Phosphoric Acid SCHEMBL27780172 0.92 PNP (0.43) PNPDPP4PDPK1GDAALDH1A1
SCHEMBL41788 0.81 PNP (0.50) PNPDPP4PDPK1GDAALDH1A1
SCHEMBL2983851 0.79 PNP (0.49) PNPDPP4PDPK1GDAALDH1A1
SCHEMBL1843777 0.79 PNP (0.49) PNPDPP4PDPK1GDAALDH1A1
SCHEMBL2051365 0.79 PNP (0.49) PNPDPP4PDPK1GDAALDH1A1
SCHEMBL8886040 0.79 PNP (0.49) PNPDPP4PDPK1GDAALDH1A1
SCHEMBL20579 0.79 DPP4 (0.50) PNPDPP4PDPK1GDAALDH1A1
SCHEMBL20867 0.79 ATAD2 (0.53) PNPDPP4PDPK1GDALMNA
SCHEMBL852108 0.79 PNP (0.49) PNPDPP4PDPK1GDAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119265192-A Compound of modified nucleotide monomer and application of compound in RNAi (ribonucleic acid interference) medicament 纳肽得(青岛)生物医药有限公司 2025-01-07 — — CN disclosed
CN-118834250-A Novel delivery vehicle 纳肽得(青岛)生物医药有限公司 2024-10-25 — — CN disclosed
CN-118834255-A Novel modified nucleotide and application thereof in RNAi (ribonucleic acid interference) medicament 纳肽得(青岛)生物医药有限公司 2024-10-25 — — CN disclosed
CN-118813612-A Application of compound in RNAi (ribonucleic acid interference) medicament 纳肽得(青岛)生物医药有限公司 2024-10-22 — — CN disclosed
CN-117737057-A Small nucleic acid sequence with enhanced anti-hepatitis B effect and conjugate thereof 纳肽得(青岛)生物医药有限公司 2024-03-22 — — CN disclosed
CN-117363614-A SiRNA for inhibiting expression of angiotensinogen and application thereof 纳肽得(青岛)生物医药有限公司 2024-01-09 — — CN disclosed
CN-117363615-A SiRNA for inhibiting complement C5 expression and application thereof 纳肽得(青岛)生物医药有限公司 2024-01-09 — — CN disclosed
CN-114401736-A PALM for the treatment of chemotherapy-induced peripheral neuropathy occurring with cancer treatment 佩蒂诺沃生物制药公司 2022-04-26 — — CN disclosed
CN-113710671-A Cyclic molecules as inhibitors of bruton's tyrosine kinase 明慧医药(上海)有限公司 2021-11-26 — — CN disclosed
CN-112739359-A APMV and its use for the treatment of cancer 西奈山伊坎医学院 2021-04-30 — — CN disclosed
CN-112533581-A PRC1 inhibitors and methods of treatment therewith 密歇根大学董事会 2021-03-19 — — CN disclosed
CN-110642910-B Thymidine derivative and preparation method and application thereof 南开大学 2020-10-30 — — CN disclosed
CN-110642910-A Thymidine derivative and preparation method and application thereof 南开大学 2020-01-03 — — CN disclosed
CN-103974724-A Modified nucleosides, nucleotides and nucleic acids and uses thereof modeRNA Therapeutics 2014-08-06 — — CN disclosed
Send feedback